SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile (ASTS) is capturing significant market attention following its selection for the Missile Defense Agency's SHIELD program, widely referred to as the 'Golden Dome' contracts. This news is fueling intense bullish sentiment among investors, who are actively discussing a potential short squeeze and forecasting substantial future growth for the company's direct-to-smartphone satellite technology.

Springview Holdings Ltd. engages in the design and construction of residential and commercial buildings. It involves new construction, reconstruction, alterations, and other general contracting services. The company was founded in 2002 and is headquartered in Singapore.

Springview Holdings Ltd - Ordinary Shares - Class A

Springview Holdings Ltd

SPHL is experiencing a significant surge, fueled by an announced partnership for solar-ready homes in Singapore and its notably low-float status. The community is actively celebrating substantial profits and engaging in fervent discussions, drawing comparisons to other parabolic runners and anticipating further volatility and gains. Traders are closely monitoring this micro-cap's dramatic price action, which has ignited widespread interest and speculation.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is trending after securing a substantial new multi-year agreement with the Swedish Armed Forces, adding to a series of significant satellite services contracts signed over the past year. This strategic expansion into geo-intelligence solutions, alongside strong financial indicators, has ignited community excitement, with many discussing its remarkable price movement and future potential within the dynamic space sector.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science (MLEC) is trending following a recent reverse stock split that significantly tightened its public float, intensifying speculation around a potential short squeeze. The community is actively discussing its ultra-low share count and recent regulatory approval for its safflower GLASO technology in Argentina, fueling comparisons to other high-volatility low-float plays. Traders are closely monitoring the stock for continued momentum as the company expands its commercialization efforts.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

Satoshi Crypto ($SATOSHI) is gaining significant traction and trending as its cultural influence expands, notably with public figures embracing Satoshi Nakamoto apparel. The community emphasizes its role as the ultimate narrative in crypto, viewing it as the "Bitcoin of memes" and a monumental tokenization of the industry's core identity. Many believe its timeless relevance and decentralized nature present an unmatched opportunity for long-term holders.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending due to a significant insider stock purchase near all-time highs, sparking community confidence in its robust fundamentals and undervalued status. Discussions are fueled by numerous analyst upgrades, the company's critical role as the sole US HBM supplier for escalating AI demand, and its ongoing major expansion efforts.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN is trending with its "Like Bitcoin but way higher" mantra, drawing attention as a Solana-based memecoin deeply rooted in cannabis culture. The community emphasizes building a long-term "Green Wave" movement around plant-based wellness, agriculture, and cultural sovereignty, highlighting consistency and positivity.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America and Australia (NAA) Cruise, Europe and Asia (EA) Cruise Operations, Cruise Support, and Tour and Others. The North America and Australia (NAA) Cruise segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe and Asia (EA) Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corp. - Ordinary Shares (Paired Stock)

Carnival Corp

Carnival Corp. (CCL) is trending following its robust earnings report, which showcased record profits, strong forward bookings, and the reinstatement of its dividend. The community is actively discussing the company's improved financial health and investment-grade metrics, viewing these as strong indicators for future growth. While some investors voice frustration over perceived market manipulation and potential pullbacks, the predominant sentiment is bullish, fueled by analyst upgrades and confidence in the cruise industry's recovery.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems (OSS) is trending due to significant anticipation surrounding potential multi-year opportunities, estimated at up to $200 million, in both the defense and datacenter markets. The community is buzzing about OSS as an undervalued "Edge AI" and high-performance computing play, highlighting its strategic positioning for substantial growth following recent contract momentum and a focused shift in its business.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending due to significant validation of its Optical Interposer technology, notably through Marvell's acquisition of key customer Celestial AI and Mitsubishi's increased optical semiconductor production. The community is highly optimistic about POET's innovative passive alignment architecture, which is seen as a cost-effective and scalable solution for high-speed optical interconnects crucial to the burgeoning AI data center market. This has fueled anticipation for upcoming large orders and a potential re-rating of the stock.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Maze Therapeutics (NASDAQ:MAZE) CMO Sells 25,156 Shares

Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) CMO Harold Bernstein sold 25,156 shares of the business's stock in a transaction dated Wednesday, January 7th. The stock was sold at an average...

Maze Therapeutics (NASDAQ:MAZE) CMO Harold Bernstein Sells 4,432 Shares

Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) CMO Harold Bernstein sold 4,432 shares of the stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of...

Insider Selling: Maze Therapeutics (NASDAQ:MAZE) CMO Sells 412 Shares of Stock

Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) CMO Harold Bernstein sold 412 shares of the company's stock in a transaction on Monday, January 5th. The stock was sold at an average price of...

Harold Bernstein Sells 4,432 Shares of Maze Therapeutics (NASDAQ:MAZE) Stock

Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) CMO Harold Bernstein sold 4,432 shares of the business's stock in a transaction on Friday, January 2nd. The stock was sold at an average price...

Maze Therapeutics (NASDAQ:MAZE) SVP Amy Bachrodt Sells 5,000 Shares

Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) SVP Amy Bachrodt sold 5,000 shares of Maze Therapeutics stock in a transaction dated Friday, January 2nd. The stock was sold at an average...

Maze Therapeutics (NASDAQ:MAZE) Trading Down 4.9% - Here's Why

Maze Therapeutics (NASDAQ:MAZE) Trading Down 4.9% - Time to Sell...

Insider Selling: Maze Therapeutics (NASDAQ:MAZE) CMO Sells 45,000 Shares of Stock

Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) CMO Harold Bernstein sold 45,000 shares of the company's stock in a transaction that occurred on Monday, December 29th. The shares were sold at...

Insider Selling: Maze Therapeutics (NASDAQ:MAZE) SVP Sells 5,000 Shares of Stock

Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) SVP Amy Bachrodt sold 5,000 shares of the firm's stock in a transaction that occurred on Tuesday, December 30th. The stock was sold at an...

Amy Bachrodt Sells 10,000 Shares of Maze Therapeutics (NASDAQ:MAZE) Stock

Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) SVP Amy Bachrodt sold 10,000 shares of the stock in a transaction dated Monday, December 29th. The stock was sold at an average price of...

Maze Therapeutics (NASDAQ:MAZE) Insider Sells $2,936,544.00 in Stock

Maze Therapeutics, Inc. (NASDAQ:MAZE - Get Free Report) insider Atul Dandekar sold 72,400 shares of Maze Therapeutics stock in a transaction that occurred on Monday, December 29th. The stock was sold...

Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM diseases. Its pipeline includes the Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process to refer a variant functionalization. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman on August 29, 2017 and is headquartered in San Francisco, CA.

Maze Therapeutics Inc.

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.71	--	--	N/A
Q3 '25	-$0.71	-$0.66	6.80%	BEAT
Q2 '25	-$0.84	-$0.77	7.90%	BEAT
Q1 '25	-$0.72	-$1.15	-59.02%	MISSED
Q4 '24	$2.05	-$18.32	-993.66%	MISSED

MAZE
Maze Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest MAZE News

MAZEMaze Therapeutics Inc.